Skip to main content

Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Johnson & Johnson (NYSE: JNJ) will participate in the 2024 RBC Capital Markets Global Healthcare Conference on Wednesday, May 15th, at the InterContinental Barclay Hotel, New York. Tim Schmid, Executive Vice President, Worldwide Chairman, MedTech, will represent the Company in a session scheduled at 11:00 am (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  240.01
-0.13 (-0.05%)
AAPL  288.22
+6.48 (2.30%)
AMD  577.06
+37.57 (6.96%)
BAC  57.27
-0.61 (-1.05%)
GOOG  354.45
+3.17 (0.90%)
META  556.13
-6.47 (-1.15%)
MSFT  370.77
+2.20 (0.60%)
NVDA  197.82
+2.85 (1.46%)
ORCL  146.10
-1.66 (-1.12%)
TSLA  416.74
+4.90 (1.19%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.